Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 05 Mar 2015  |  Global  |  Market Research

    Growth Drivers for Biomarkers in Healthcare

    Managing Success in the Biomarker Industry—Challenges and Opportunities

    Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...

    $2,450.00

    Special Price $1,837.50 save 25 %

  2. 26 Feb 2015  |  Global  |  Market Research

    Regulatory Trends in the US Pharma/Biotech Industry

    Efficiency of the FDA Review Process Expedites Access to Care

    This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinsons Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessmen...

    $1,500.00

    Special Price $1,125.00 save 25 %

  3. 04 Feb 2015  |  Global  |  Market Research

    Global CRO Market

    Transformation, Developments, Opportunities and Future of CRO Market

    This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...

    $4,950.00

    Special Price $3,712.50 save 25 %

  4. 19 Dec 2013  |  Global  |  Market Research

    Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

    Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets

    Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...

    $2,450.00

    Special Price $1,837.50 save 25 %

  5. 17 Dec 2013  |  Global  |  Market Research

    World LED Lighting Markets (2013 Update)

    Government Initiatives and Declining Prices are Driving the High Growth

    The key challenges that the LED lighting market face are the prevalence of alternate technologies and high initial investment. Raising awareness amidst residential end users, financing projects, and leasing and maintenance of lighting solutions in the professional lighting market can tackle these challenges and provide untapped opportunities. End u...

    $3,950.00

    Special Price $2,962.50 save 25 %

  6. 11 Dec 2013  |  Global  |  Market Research

    Analysis of the US Retinal Therapeutics Market

    Improvements in Administration and Efficacy Drive Growth

    The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. 31 Oct 2013  |  Global  |  Market Research

    Chinas 2013 Life Sciences Industry Outlook and Regulatory Review

    Government Investments Could Make China the Third-largest Pharmaceutical Market in the World

    China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...

    $4,950.00

    Special Price $3,712.50 save 25 %

  8. 15 Oct 2013  |  Global  |  Market Research

    A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets

    High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce

    Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well...

    $3,950.00

    Special Price $2,962.50 save 25 %

  9. 08 Oct 2013  |  Global  |  Market Research

    Global Next Generation Sequencing Informatics Market

    Informatics Vendors Flock to Growth in Sequencing Adoption

    More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. 30 Apr 2013  |  Global  |  Market Research

    Outsourcing to CMOs in Emerging EconomiesBoon or Bane?

    Analyzing the Prospects of CMOs in Emerging Markets

    This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

    $1,500.00

    Special Price $1,125.00 save 25 %